PPT-Introduction This optimal pathway is primarily designed to improve outcomes in lung cancer
Author : chozen851 | Published Date : 2024-09-06
Use of guidelines The diagnosis staging and fitness assessments in this pathway should be completed with reference to current national guidelines The NOLCP is also
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Introduction This optimal pathway is pr..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Introduction This optimal pathway is primarily designed to improve outcomes in lung cancer: Transcript
Use of guidelines The diagnosis staging and fitness assessments in this pathway should be completed with reference to current national guidelines The NOLCP is also supported by a series of Diagnostic Standards of Care. Each year more people die of lung cancer than of colon breast and prostate canc ers combined Most lung cancers could be prevented because they are related to smoking or secondhand smoke or less often to exposure to radon or other environmental facto .. . Preliminary results. . Dimitra . Kerdidani. , . Vaso. . Karavana. , Sofia . Magkouta. , Aggeliki . Meligova. , Charis Roussos, Spyros . Zakynthinos. , Ioannis . Kalomenidis. , Maria Tsoumakidou. . Albert A. Rizzo, MD FACP FCCP. Section Chief Pulmonary/ Critical Care Medicine. Christiana Care Health System, Newark De. &. Immediate Past-Chair. National Board of Directors . American Lung Association. forward. May 2016. “. People . affected by cancer . – those living with it and those supporting relatives or friends with a diagnosis – . are the driving force for change.. We know our survival rates are not good enough in this country, we know we can do more to . Pilot audit . results. Dr Allan Green/Dr Stephen Glancy, Radiology, NHS Lothian. Referrals. 28 referrals. 1 patient refused scan; 1 request was actually for CT brain; 1 should have been an Ultrasound. Consequences of the Lack of Patients of color & Structural barriers to Quality. Christopher S. Lathan, M.D., M.S., M.P.H. Assistant Professor of Medicine. Faculty Director of Cancer Care Equity, Dana-Farber Cancer Institute. Jaime Rivas, MD . Source: Center for Disease Control and Prevention, KERA Research. Hip Fracture by the Numbers. Assessed outcomes. Risk for complications. Delirium. Constipation. Readmission rate. Developed coordinated multi-disciplinary care pathway. Jaime Rivas, MD . Source: Center for Disease Control and Prevention, KERA Research. Hip Fracture by the Numbers. Assessed outcomes. Risk for complications. Delirium. Constipation. Readmission rate. Developed coordinated multi-disciplinary care pathway. Dr Louise Brown. North Manchester General Hospital. Clinical Lead for Lung Cancer, NE Sector. What is Prehab ?. What is Prehab ?. Lung Surgical Pathway. Lung Surgical Pathway. Surgical risk. 2% . mortality rate . Lung Cancer: Medical Aspects of Causation. Aneuploidy. Unlimited cell reproduction and failure of cell death. Animal Studies. Basic Toxicology. New Data on Causation. New Studies. New Statistics. Number of cases. Pathway for Lung Cancer. Somerset, Wiltshire, Avon and Gloucester Cancer Alliance Transformation Project Update. Project Milestone achievement. Deliverable / milestone. Salisbury NHS Foundation Trust. 28/09/21. Please note: This slideshow contains sensitive and unpublished data for performance management purposes and is not for sharing outside of the South West NHS. . Data from April 2021 is Provisional.. Mason Alford, MSc. a. , . Candace J. Grisham, MS. a. , . Christopher Thompson, PhD. b. , . Wade T. Iams. , MD, MSCI. c. Evaluating the Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Patients with Breast and Non-Small Cell Lung Cancer (NSCLC). Michelle Mello. Clinical Lead, Personalised Care Group. Professor Muir Gray. Clinical Advisor, NHS RightCare. . Awareness is the . 1. st . step to population. healthcare. improvement. If . the existence of clinical and financial variation is...
Download Document
Here is the link to download the presentation.
"Introduction This optimal pathway is primarily designed to improve outcomes in lung cancer"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents